Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-108604
Filing Date
2021-08-23
Accepted
2021-08-23 16:53:22
Documents
71
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM- 10Q rnaz-20210630x10q.htm   iXBRL 10-Q 1829749
2 EXHIBIT-31.1 rnaz-20210630xex31d1.htm EX-31.1 15388
3 EXHIBIT-31.2 rnaz-20210630xex31d2.htm EX-31.2 15470
4 EXHIBIT-32.1 rnaz-20210630xex32d1.htm EX-32.1 7946
5 EXHIBIT-32.2 rnaz-20210630xex32d2.htm EX-32.2 6824
  Complete submission text file 0001104659-21-108604.txt   6559716

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20210630.xsd EX-101.SCH 56784
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnaz-20210630_cal.xml EX-101.CAL 31216
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnaz-20210630_def.xml EX-101.DEF 148062
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20210630_lab.xml EX-101.LAB 429352
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20210630_pre.xml EX-101.PRE 329435
11 EXTRACTED XBRL INSTANCE DOCUMENT rnaz-20210630x10q_htm.xml XML 957220
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40363 | Film No.: 211197539
SIC: 2834 Pharmaceutical Preparations